NASDAQ:KDNY

Chinook Therapeutics News Headlines

$15.90
+0.66 (+4.33 %)
(As of 04/16/2021 04:00 PM ET)
Add
Compare
Today's Range
$15.26
Now: $15.90
$15.93
50-Day Range
$13.60
MA: $16.66
$19.11
52-Week Range
$10.50
Now: $15.90
$21.68
Volume112,826 shs
Average Volume120,219 shs
Market Capitalization$673.79 million
P/E RatioN/A
Dividend YieldN/A
Beta0.26

Headlines

Chinook Therapeutics (NASDAQ KDNY) News Headlines Today

SourceHeadline
Chinook Therapeutics (NASDAQ:KDNY) Trading 6.4% Higher Chinook Therapeutics (NASDAQ:KDNY) Trading 6.4% Higher
americanbankingnews.com - April 15 at 1:18 PM
Chinook Therapeutics, Inc. (NASDAQ:KDNY) Receives Average Recommendation of "Buy" from AnalystsChinook Therapeutics, Inc. (NASDAQ:KDNY) Receives Average Recommendation of "Buy" from Analysts
americanbankingnews.com - April 15 at 10:48 AM
Chinook Therapeutics Presents Data During the ISN World Congress of Nephrology 2021Chinook Therapeutics Presents Data During the ISN World Congress of Nephrology 2021
finance.yahoo.com - April 15 at 9:15 AM
Q1 2021 EPS Estimates for Chinook Therapeutics, Inc. (NASDAQ:KDNY) Lowered by AnalystQ1 2021 EPS Estimates for Chinook Therapeutics, Inc. (NASDAQ:KDNY) Lowered by Analyst
americanbankingnews.com - April 15 at 6:32 AM
Q1 2021 EPS Estimates for Chinook Therapeutics, Inc. Reduced by Wedbush (NASDAQ:KDNY)Q1 2021 EPS Estimates for Chinook Therapeutics, Inc. Reduced by Wedbush (NASDAQ:KDNY)
americanbankingnews.com - April 12 at 1:24 AM
Chinook Therapeutics (NASDAQ:KDNY) Issues Quarterly  Earnings ResultsChinook Therapeutics (NASDAQ:KDNY) Issues Quarterly Earnings Results
americanbankingnews.com - April 8 at 7:22 AM
Chinook Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial ResultsChinook Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results
finance.yahoo.com - April 7 at 6:31 PM
Chinook Therapeutics Announces First Patient Dosed in Phase 2 AFFINITY Basket Study of Atrasentan in Proteinuric Glomerular DiseasesChinook Therapeutics Announces First Patient Dosed in Phase 2 AFFINITY Basket Study of Atrasentan in Proteinuric Glomerular Diseases
finance.yahoo.com - April 7 at 8:30 AM
Chinook Therapeutics Announces Update on Non-Renal Legacy Programs from Aduro Biotech MergerChinook Therapeutics Announces Update on Non-Renal Legacy Programs from Aduro Biotech Merger
finance.yahoo.com - April 5 at 8:35 AM
Chinook Therapeutics, Inc. Forecasted to Post Q1 2022 Earnings of ($0.58) Per Share (NASDAQ:KDNY)Chinook Therapeutics, Inc. Forecasted to Post Q1 2022 Earnings of ($0.58) Per Share (NASDAQ:KDNY)
americanbankingnews.com - April 2 at 9:06 AM
Chinook (KDNY) Surges 7%: Is This an Indication of Further Gains?Chinook (KDNY) Surges 7%: Is This an Indication of Further Gains?
finance.yahoo.com - March 31 at 2:33 PM
Chinook Therapeutics (NASDAQ:KDNY) Trading Down 9%Chinook Therapeutics (NASDAQ:KDNY) Trading Down 9%
americanbankingnews.com - March 31 at 12:00 PM
Chinook Therapeutics Announces Upcoming Data Presentations at ISN World Congress of Nephrology 2021 and 58th ERA-EDTA CongressChinook Therapeutics Announces Upcoming Data Presentations at ISN World Congress of Nephrology 2021 and 58th ERA-EDTA Congress
finance.yahoo.com - March 30 at 6:30 PM
Chinook Therapeutics (NASDAQ:KDNY) Sees Strong Trading VolumeChinook Therapeutics (NASDAQ:KDNY) Sees Strong Trading Volume
americanbankingnews.com - March 30 at 11:45 AM
Chinook Therapeutics (NASDAQ:KDNY) Stock Price Down 4.8%Chinook Therapeutics (NASDAQ:KDNY) Stock Price Down 4.8%
americanbankingnews.com - March 25 at 1:20 PM
Chinook Therapeutics (NASDAQ:KDNY) Receives Buy Rating from Bloom BurtonChinook Therapeutics (NASDAQ:KDNY) Receives Buy Rating from Bloom Burton
americanbankingnews.com - March 25 at 9:40 AM
Chinook Therapeutics (NASDAQ:KDNY) Sees Large Volume IncreaseChinook Therapeutics (NASDAQ:KDNY) Sees Large Volume Increase
americanbankingnews.com - March 24 at 3:12 PM
Chinook Therapeutics Announces First Patient Enrolled in Pivotal Phase 3 ALIGN Study of Atrasentan for Patients with IgA NephropathyChinook Therapeutics Announces First Patient Enrolled in Pivotal Phase 3 ALIGN Study of Atrasentan for Patients with IgA Nephropathy
finance.yahoo.com - March 16 at 10:09 AM
Chinook Therapeutics, Inc. Rings the Nasdaq Stock Market Closing BellChinook Therapeutics, Inc. Rings the Nasdaq Stock Market Closing Bell
nasdaq.com - March 5 at 5:57 PM
Will Chinook Therapeutics (KDNY) Report Negative Q4 Earnings? What You Should KnowWill Chinook Therapeutics (KDNY) Report Negative Q4 Earnings? What You Should Know
finance.yahoo.com - March 1 at 8:29 PM
Chinook Therapeutics and Evotec Announce Strategic Collaboration to Discover and Develop Novel Precision Medicines for Chronic Kidney DiseasesChinook Therapeutics and Evotec Announce Strategic Collaboration to Discover and Develop Novel Precision Medicines for Chronic Kidney Diseases
finance.yahoo.com - March 1 at 10:28 AM
Evotec, Chinook Collaborate To Discover & Develop Medicines For Chronic Kidney DiseasesEvotec, Chinook Collaborate To Discover & Develop Medicines For Chronic Kidney Diseases
nasdaq.com - March 1 at 5:27 AM
Chinook Therapeutics to Present at 3rd Annual Chronic Kidney Disease Drug Development (CKD3) SummitChinook Therapeutics to Present at 3rd Annual Chronic Kidney Disease Drug Development (CKD3) Summit
finance.yahoo.com - February 23 at 8:47 AM
Chinook Therapeutics to Present at the 10th Annual SVB Leerink Global Healthcare ConferenceChinook Therapeutics to Present at the 10th Annual SVB Leerink Global Healthcare Conference
finance.yahoo.com - February 17 at 6:51 PM
Chinook Receives Rare Pediatric Disease Designation from U.S. Food and Drug Administration for CHK-336 for Treatment of Primary HyperoxaluriaChinook Receives Rare Pediatric Disease Designation from U.S. Food and Drug Administration for CHK-336 for Treatment of Primary Hyperoxaluria
finance.yahoo.com - February 2 at 8:31 AM
Who Has Been Buying Chinook Therapeutics, Inc. (NASDAQ:KDNY) Shares?Who Has Been Buying Chinook Therapeutics, Inc. (NASDAQ:KDNY) Shares?
finance.yahoo.com - January 7 at 1:37 PM
Chinook Therapeutics Announces License Agreement with Morehouse School of Medicine for Development of Therapies in Kidney Diseases Disproportionately Affecting African Americans and Underserved CommunitiesChinook Therapeutics Announces License Agreement with Morehouse School of Medicine for Development of Therapies in Kidney Diseases Disproportionately Affecting African Americans and Underserved Communities
finance.yahoo.com - December 8 at 11:53 AM
Chinook Therapeutics Announces New Employment Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)Chinook Therapeutics Announces New Employment Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
finance.yahoo.com - November 30 at 6:15 PM
Chinook Therapeutics to Present at Upcoming Investor ConferencesChinook Therapeutics to Present at Upcoming Investor Conferences
finance.yahoo.com - November 18 at 6:49 PM
Chinook Therapeutics Announces Appointment of Eric Bjerkholt as Chief Financial OfficerChinook Therapeutics Announces Appointment of Eric Bjerkholt as Chief Financial Officer
finance.yahoo.com - November 10 at 8:34 AM
Aduro Biotech (KDNY) Reports Q3 Loss, Tops Revenue EstimatesAduro Biotech (KDNY) Reports Q3 Loss, Tops Revenue Estimates
nasdaq.com - November 5 at 11:18 PM
Chinook Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business UpdateChinook Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update
finance.yahoo.com - November 5 at 6:18 PM
ADURO BIOTECH DL-,0001 (290.DU)ADURO BIOTECH DL-,0001 (290.DU)
ca.finance.yahoo.com - October 17 at 9:03 AM
Aduro Biotech (KDNY) Upgraded to Buy: Heres What You Should KnowAduro Biotech (KDNY) Upgraded to Buy: Here's What You Should Know
nasdaq.com - October 16 at 1:35 PM
Chinook Therapeutics Announces Upcoming Data Presentations and Investor Conference Call During the American Society of Nephrology (ASN) Kidney Week 2020 ReimaginedChinook Therapeutics Announces Upcoming Data Presentations and Investor Conference Call During the American Society of Nephrology (ASN) Kidney Week 2020 Reimagined
finance.yahoo.com - October 13 at 8:29 PM
Heres Why Momentum Investors Will Love Aduro Biotech (KDNY)Here's Why Momentum Investors Will Love Aduro Biotech (KDNY)
nasdaq.com - October 13 at 3:26 PM
This page was last updated on 4/17/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.